// App-Quantinova.ai

5858 : Development of a translation elongation inhibitor for the treatment of cancer

Researchers

Presenter

  • Nathan Gomes

Principal Investigators

  • Barb Frederick

  • Daniel Gustafson

  • Bert Pronk

  • Tin Tin Su

Medical Centers

  • University of Colorado, Boulder, CO.

  • Colorado State University, Fort Collins, CO

  • SuviCa Inc, CO.

Locations

  • United States

Companies

  • SuviCa, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • bouvardin

  • Cisplatin

  • SVC112

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved